Although the result did not reach statistical significance, it suggested a possible reduction in recurrence (Fig. 2 D).
← all excerpts
Comparative efficacy of ceftolozane-tazobactam versus ceftazidime-avibactam for <i>Pseudomonas aeruginosa</i> infections: a GRADE-assessed systematic review and meta-analysis.
1
—
—